The 36 linked references in paper A. Stukan' I., O. Chukhray Yu., V. Porkhanov A., R. Murashko A., V. Bodnya N., Yu. Makarova M., А. Стукань И., О. Чухрай Ю., В. Порханов А., Р. Мурашко А., В. Бодня H., Ю. Макарова М. (2018) “Орофарингеальная карцинома, ассоциированная с вирусом папилломы человека: тенденции эпидемиологии и методы выявления вируса в опухоли // Human papillomavirus-associated oropharyngeal carcinoma: trends in epidemiology and methods for detecting the virus in tumors” / spz:neicon:ogsh:y:2018:i:3:p:77-83

  1. Kofler B., Laban S., Busch C. J. et al. New treatment strategies for HPV-positive head and neck cancer. Eur Arch Otorhinolaryngol 2014;271(7):1861–7. DOI: 10.1007/s00405-013-2603-0. PMID: 23934317.
  2. Smith E. M., Ritchie J. M., Summersgill K. F. et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004;108(5):766–72. DOI: 10.1002/ ijc.11633. PMID: 14696105.
  3. Chaturvedi A. K., Engels E. A., Anderson W. F., Gillison M. L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26(4):612–9. DOI: 10.1200/jco.2007.14.1713. PMID: 18235120.
  4. Mehta V., Yu G. P., Schantz S. P. Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics. Laryngoscope 2010;120(11):2203–12. DOI: 10.1002/lary.21129. PMID: 20938956.
  5. Brown L. M., Check D. P., Devesa S. S. Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns. J Oncol 2012;2012:649498. DOI: 10.1155/2012/649498. PMID: 22577381.
  6. Hong A. M., Martin A., Chatfield M. et al. Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. Int J Cancer 2013;132(12): 2748–54. DOI: 10.1002/ijc.27956. PMID: 23180456.
  7. Gillison M. L., D’Souza G., Westra W. et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100(6):407–20. DOI: 10.1093/jnci/djn025. PMID: 18334711.
  8. Bajos N., Bozon M., Beltzer N. et al. Changes in sexual behaviours: from secular trends to public health policies. AIDS 2010;24(8):1185–91. DOI: 10.1097/qad. 0b013e328336ad52. PMID: 20299962.
  9. D’Souza G., Agrawal Y., Halpern J. et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009;199(9):1263–9. DOI: 10.1086/597755. PMID: 19320589.
  10. Heck J. E., Berthiller J., Vaccarella S. et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010; 39(1):166–81. DOI: 10.1093/ije/dyp350. PMID: 20022926.
  11. Dahlstrom K. R., Li G., TortoleroLuna G. et al. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck 2011;33(6):847–55. DOI: 10.1002/hed.21550. PMID: 20737488.
  12. Herrero R., Castellsagué X., Pawlita M. et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95(23):1772–83. DOI: 10.1093/jnci/djg107. PMID: 14652239.
  13. D’Souza G., Kreimer A. R., Viscidi R. et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356(19):1944–56. DOI: 10.1056/nejmoa065497. PMID: 17494927.
  14. D’Souza G., Zhang H. H., D’Souza W. D. et al. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol 2010;46(2):100–4. DOI: 10.1016/j.oraloncology.2009.11.004. PMID: 20036610.
  15. Chaturvedi A. K., Engels E. A., Pfeiffer R. M. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29(32):4294–301. DOI: 10.1200/jco.2011.36.4596. PMID: 21969503.
  16. Hong A. M., Grulich A. E., Jones D. et al. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 2010;28(19):3269–72. DOI: 10.1016/j.vaccine.2010.02.098. PMID: 20226244.
  17. Dahlstrom K. R., Calzada G., Hanby J. D. et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer 2013;119(1):81–9. DOI: 10.1002/cncr. 27727. PMID: 22736261.
  18. Rainsbury J. W., Ahmed W., Williams H. K. et al. Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and metaanalysis. Head Neck 2013;35(7):1048–55. DOI: 10.1002/hed.22950. PMID: 22997051.
  19. Mammas I. N., Sourvinos G., Zaravinos A., Spandidos D. A. Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers. Pathol Oncol Res 2011;17(1):103–19. DOI: 10.1007/s12253-010-9288-0. PMID: 20640607.
  20. Venuti A., Badaracco G., Rizzo C. et al. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res 2004;23(4):561–6. DOI: 10.3892/or. 17.4.931. PMID: 15743024.
  21. Dahlstrand H., Näsman A., Romanitan M. et al. Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 2008;28(2B):1133–8. DOI: 10.1007/978-90-481-3186-0_19. PMID: 18505048.
  22. Ryerson A. B., Peters E. S., Coughlin S. S. et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer 2008;113(10 Suppl): 2901–9. DOI: 10.1002/cncr.23745. PMID: 18980273.
  23. Li W., Tran N., Lee S. C. et al. New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis. Pathology 2007;39(2):217–22. DOI: 10.1080/00313020701230823. PMID: 17454751.
  24. Hafkamp H. C., Manni J. J., Haesevoets A. et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008;122(12):2656–64. DOI: 10.1002/ijc.23458. PMID: 18360824.
  25. Nichols A. C., Dhaliwal S. S., Palma D. A. et al. Does HPV type affect outcome in oropharyngeal cancer? J Otolaryngol Head Neck Surg 2013;42:9. DOI: 10.1186/1916-0216-42-9. PMID: 23663293.
  26. Sturgis E. M., Cinciripini P. M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110(7):1429–35. DOI: 10.1002/cncr.22963. PMID: 17724670.
  27. Hariri S., Unger E. R., Sternberg M. et al. Prevalence of genital human papillo mavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003–2006. J Infect Dis 2011;204(4):566–73. DOI: 10.1093/infdis/jir341. PMID: 21791659.
  28. Giuliano A. R., Lazcano-Ponce E., Villa L. L. et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008;17(8): 2036–43. DOI: 10.1158/1055-9965. EPI-08-0151. PMID: 18708396.
  29. Robinson M., Sloan P., Shaw R. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol 2010;46(7):492–6. DOI: 10.1016/j.oraloncology.2010.02.013. PMID: 20227331.
  30. Grønhøj Larsen C., Gyldenløve M., Jensen D. H. et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer 2014; 110(6):1587–94. DOI: 10.1038/ bjc.2014.42. PMID: 24518594.
  31. Schlect N. F., Brandwein-Gensler M., Nuovo G. J. et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol 2011;24(10):1295–305. DOI: 10.1038/modpathol.2011.91. PMID: 21572401.
  32. Langendijk J. A., Psyrri A. The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies. Ann Oncol 2010;21(10):1931–4. DOI: 10.1093/annonc/mdq439. PMID: 20716626.
  33. Lewis J. S. Jr. p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 2012;6 Suppl 1: S75–82. DOI: 10.1007/ s12105-012-0369-0. PMID: 22782226.
  34. Smeets S. J., Hesselink A. T., Speel E. J. et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121(11):2465–72. DOI: 10.1002/ijc. 22980. PMID: 17680565.
  35. Lewis J. S. Jr, Beadle B., Bishop J. A. et al. Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med 2018;142(5):559–7. DOI: 10.5858/arpa.2017-0286-CP. PMID: 29251996.
  36. Huang S. H., O’Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol 2017;18(7):40. DOI: 10.1007/s11864-017-0484-y.